240 related articles for article (PubMed ID: 28961692)
1. The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.
Gerstenecker A
Arch Clin Neuropsychol; 2017 Nov; 32(7):861-875. PubMed ID: 28961692
[TBL] [Abstract][Full Text] [Related]
2. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
3. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
[TBL] [Abstract][Full Text] [Related]
4. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD.
Kashihara K; Shinya T; Higaki F
Intern Med; 2011; 50(16):1683-7. PubMed ID: 21841326
[TBL] [Abstract][Full Text] [Related]
5. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
Kurata T; Kametaka S; Ohta Y; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Takao Y; Ohta T; Manabe Y; Sato S; Abe K
Intern Med; 2011; 50(22):2775-81. PubMed ID: 22082889
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.
Bruns MB; Josephs KA
Int Rev Psychiatry; 2013 Apr; 25(2):197-209. PubMed ID: 23611349
[TBL] [Abstract][Full Text] [Related]
7. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
Fabbrini G; Fabbrini A; Suppa A
Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
[TBL] [Abstract][Full Text] [Related]
8. Pathological heterogeneity in progressive supranuclear palsy and corticobasal degeneration.
Wakabayashi K; Takahashi H
Neuropathology; 2004 Mar; 24(1):79-86. PubMed ID: 15068177
[TBL] [Abstract][Full Text] [Related]
9. [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.
Pirker W; Asenbaum S; Bencsits G; Prayer D; Gerschlager W; Deecke L; Brücke T
Mov Disord; 2000 Nov; 15(6):1158-67. PubMed ID: 11104200
[TBL] [Abstract][Full Text] [Related]
10. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
Bak TH; Crawford LM; Hearn VC; Mathuranath PS; Hodges JR
Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227
[TBL] [Abstract][Full Text] [Related]
11. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
Kertesz A; McMonagle P
J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792
[TBL] [Abstract][Full Text] [Related]
13. Co-occurrence of radiological features of progressive supranuclear palsy and corticobasal degeneration.
Divatia R; Khan F; Kishore A
Neurol India; 2007; 55(1):75-7. PubMed ID: 17272907
[TBL] [Abstract][Full Text] [Related]
14. Analysis of PITX3 gene in patients with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration.
Jamrozik Z; Berdynski M; Zekanowski C; Baranczyk-Kuzma A; Sławek J; Kuzma-Kozakiewicz M; Maruszak A; Kwiecinski H
Ann Clin Lab Sci; 2013; 43(2):151-3. PubMed ID: 23694789
[TBL] [Abstract][Full Text] [Related]
15. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
[TBL] [Abstract][Full Text] [Related]
16. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
[TBL] [Abstract][Full Text] [Related]
17. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
Lass P; Sławek J; Derejko M; Dubaniewicz M
Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
[TBL] [Abstract][Full Text] [Related]
18. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
20. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A; Munoz D
Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
